Where Is Staphylococcus Epidermidis Found?

Staphylococcus epidermidis lives on nearly every patch of human skin, making it one of the most abundant bacterial residents of the human body. It colonizes your forehead, your armpits, the webs between your toes, the surface of your eyes, and the inside of your nostrils, among other sites. But its range extends well beyond healthy skin. S. epidermidis also thrives on medical implants, hospital surfaces, clothing fibers, and food-processing equipment, and its behavior in each of these environments tells a different story about what this microbe is capable of.

A Resident of Nearly Every Skin Site

S. epidermidis is not just “on your skin” in some vague sense. It populates distinct skin environments across the entire body, from oily zones like the face and scalp to dry patches on the forearms and moist folds like the groin and toe webs. A large genomic study that sequenced over 1,400 S. epidermidis isolates from 16 different skin sites on healthy volunteers found that populations varied in a site-specific way. Toe web isolates, for instance, clustered together in a surprisingly narrow genetic range, not just within one person but across all five subjects in the study.¹ That means toe web S. epidermidis looks more like “toe web S. epidermidis” than like “your S. epidermidis,” which says something interesting about how deeply the microbe has adapted to specific micro-environments on the body.

A related analysis of the same dataset estimated that any given person’s skin S. epidermidis population was likely established by at least 12 to 20 distinct founder strains, not a single colonizer that spread everywhere.² These founder lineages mixed and swapped genes over time, meaning that the S. epidermidis on your cheek and the S. epidermidis in your armpit are likely related but not identical, shaped by the specific conditions of each spot.

The Nose, Eyes, and Deeper Structures

Skin is the headline habitat, but S. epidermidis extends into several mucosal and semi-enclosed niches as well. The anterior nares, the front part of your nostrils, are a well-documented reservoir. One study of over 200 people found that roughly a quarter to a third carried the bacterium in their nose, depending on sex, with nasal carriage at about 28% in women and 33% in men.³ The anterior nares also harbor bacteriophages (viruses that infect bacteria) targeting S. epidermidis, found in about 5.5% of subjects in one survey, suggesting that even in this small niche there is an active predator-prey dynamic playing out at the microbial level.⁴

The surface of the eye is another colonization site. S. epidermidis is considered part of the normal bacterial flora on the ocular surface, and multiple genetically distinct strains can coexist there simultaneously.⁵ This polyclonal presence, meaning several genetically distinct lineages living side by side, mirrors the pattern researchers see on the skin and suggests that the eye surface is not simply receiving stray bacteria from nearby skin but maintaining its own resident community.

How It Arrives and How It Changes Over a Lifetime

Colonization with S. epidermidis begins very early. Preterm infants in neonatal intensive care units have been shown to acquire competing S. epidermidis strains on their skin within the first weeks of life. Research on preterm infant skin found that one common strain type (ST2) tended to colonize first, but was frequently replaced over time by a rival strain type (ST59), with the two showing antagonistic dynamics, meaning where one thrived the other tended to decline.⁶ This early jockeying for position hints that establishing a skin foothold is not passive. Even among strains of the same species, there is real competition.

Abundance changes with age. A study tracking the skin microbiome of males from birth to 25 years found that S. epidermidis tended to increase in abundance as subjects matured.⁷ In adults, the species remains a prominent community member. A study of aging-related skin microbiome changes in a UK cohort identified S. epidermidis as one of the primary drivers of a high-diversity community type found across multiple body sites.⁸

Stability at the species level masks a lot of turnover underneath. Although S. epidermidis is always detectable on adult skin, the particular lineages present are constantly shuffling. A longitudinal family study found that individual lineages generally persist for only a matter of years despite the species appearing stable overall. Adults showed more stability than children: the median time a lineage had been present was about two years for parents compared to roughly half a year to just over a year for their children.⁹ So while you will always have S. epidermidis, the specific strains come and go, replaced by new arrivals from the environment or from people around you.

Medical Devices and Hospital Surfaces

The clinical significance of S. epidermidis stems largely from where it goes when it leaves healthy skin and finds its way onto implanted materials. It is the most common cause of infections on prosthetic joints, heart valves, pacemakers, and indwelling catheters, largely because it excels at forming biofilms on plastic and metal surfaces.¹⁰ A biofilm is essentially a sticky, structured mat of bacteria embedded in a self-produced slime that protects them from antibiotics and the immune system. S. epidermidis has become a leading organism in biofilm research precisely because of how efficiently it builds these structures on device surfaces.¹¹

Outside of devices still inside a patient, S. epidermidis also persists on hospital surfaces for surprisingly long stretches. Studies on the survival of pathogens on inanimate surfaces have shown that S. epidermidis can last more than 25 days on cotton lint and over seven hours on glass with virtually no drop in viable cell counts.¹² That kind of environmental persistence means that hospital bedding, surgical drapes, and shared equipment can serve as reservoirs for transmission. In some hospitals, specific drug-resistant S. epidermidis clones have been tracked persisting in the facility for over a decade, becoming essentially endemic to the hospital environment.¹³

Clothing, Food, and Animals

You shed S. epidermidis onto your clothes constantly. A study comparing microbial communities on cotton and polyester workout clothes after exercise found staphylococci, including S. epidermidis, in abundance on both fabric types.¹⁴ Interestingly, the fiber composition of clothing influenced which microbes thrived, which in turn affected the intensity of body odor. The connection between S. epidermidis and your gym clothes is not just trivia. It underscores how readily the bacterium transfers from skin to the everyday objects around you.

Food production is another off-body niche. A survey of raw materials, processed foods, and contact surfaces in meat and dairy plants detected biofilm-forming S. epidermidis across all categories. Contamination was higher in finished meat and milk products compared to raw materials, and dairy-plant surfaces were more frequently contaminated than those in meat-processing facilities.¹⁵ While S. epidermidis in food is not typically considered a major safety hazard the way Salmonella or Listeria would be, its presence on food-contact surfaces speaks to how pervasive the organism is in any environment where human hands are involved.

Animals carry it too, though less commonly. A survey of healthy dog skin isolated S. epidermidis from under 10% of samples, placing it well behind the dominant canine skin staphylococci.¹⁶ Dogs have their own preferred skin staphylococci, and S. epidermidis is more of an occasional visitor on canine skin than a core resident. This reinforces the species’ strong association with humans specifically, rather than with mammalian skin in general.

Competition With Other Skin Bacteria

Where S. epidermidis lives on your skin is partly determined by its neighbors. One area of active research involves the competition between S. epidermidis and Staphylococcus aureus, its more pathogenic cousin. Both species use adhesion proteins to latch onto the outer layer of dead skin cells (corneocytes), and recent work has shown that the adhesion machinery of S. epidermidis and S. aureus targets similar sugar molecules on the skin surface. When both are present, they cross-inhibit each other’s ability to stick to corneocytes.¹⁷ This is one reason researchers are interested in S. epidermidis as a potential natural barrier against S. aureus colonization: if the benign species is already occupying the attachment sites, it may be harder for the harmful one to gain a foothold.

The competition is not limited to inter-species battles. As the preterm infant research mentioned earlier demonstrated, distinct S. epidermidis strains also compete with each other for the same skin territory. The picture that emerges is one of constant low-level warfare on your skin surface, with different microbial factions jockeying for resources and attachment points. The stability you experience at the level of “I have S. epidermidis on my skin” conceals a much more dynamic reality underneath.

Two Populations, Two Lifestyles

Not all S. epidermidis strains are the same, and where a strain is found often correlates with its genetic makeup. Genomic comparisons of commensal strains from healthy skin versus nosocomial strains from catheters and bloodstream infections have revealed that S. epidermidis genomes split into two broad phylogenetic groups. One group consists exclusively of commensal strains, the harmless skin residents. A distinguishing genetic marker is the formate dehydrogenase gene, present in commensals but absent from the hospital-associated group.¹⁸ Commensal strains had an open pan-genome, meaning the species keeps accumulating new genes rather than converging on a fixed set, which speaks to how diverse the skin-dwelling population really is.

The hospital-adapted strains, by contrast, tend to carry more antibiotic resistance genes and are more likely to possess the genetic machinery for aggressive biofilm formation. An eight-year survey at a children’s hospital in Mexico City found that about half of the multidrug-resistant S. epidermidis strains isolated there actually lacked the operon for biofilm formation, suggesting they were likely commensal strains that had picked up antibiotic resistance rather than true pathogens. Their drug resistance alone, independent of traditional virulence factors, was enough to explain their persistence in the hospital setting.¹⁹ This blurs the neat line between “harmless skin commensal” and “dangerous hospital pathogen.” A strain doesn’t necessarily need classic virulence traits to cause problems. It just needs to resist the antibiotics being thrown at it and find itself in the wrong place, like inside a catheter instead of on intact skin.

From the Operating Room to the Air

One underappreciated route of S. epidermidis dispersal is through the air, particularly in settings like surgical suites. A study of operating-room staff during cardiovascular surgery found that workers shed methicillin-resistant S. epidermidis from their skin and clothing into the surrounding air. Carriage rates on the cheek were especially high, at about 50%, while other body sites like the axilla (about 24%) and perineum (about 5%) contributed less.³ Facial skin, in other words, is a major launch pad. The bacterium hitches a ride on skin flakes that slough off continuously and become airborne, potentially landing on surgical instruments or open wounds. This is one reason surgical teams wear masks and work in laminar-flow environments, though eliminating airborne S. epidermidis entirely is essentially impossible given how heavily it colonizes the people in the room.

Why It Matters That S. Epidermidis Is Everywhere

The sheer ubiquity of S. epidermidis creates a paradox for medicine. Its near-universal presence on human skin means that when it shows up in a blood culture or on a removed catheter tip, clinicians have to decide whether it represents a genuine infection or just contamination from the patient’s own skin during sample collection. This is not a trivial distinction. False-positive blood cultures attributed to S. epidermidis contamination lead to unnecessary antibiotic courses and extended hospital stays. The genomic work distinguishing commensal from hospital-adapted lineages is partly aimed at solving this diagnostic puzzle: if you can tell from the genome whether a strain is a true pathogen or just a wandering skin resident, you can make better treatment decisions.

The flip side of the paradox is that S. epidermidis’s presence on skin is not just tolerated by the immune system, it appears to be actively beneficial. Research has explored how the species trains the skin’s immune responses and competes against more dangerous bacteria. Its dual nature, harmless symbiont on intact skin and persistent pathogen on implanted devices, makes it one of the most medically interesting bacteria despite rarely making headlines the way S. aureus or E. coli do.²⁰